Candel Therapeutics, Inc. CADL Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $194.83M+62.7% | $119.73M+37.7% | $86.96M-13.6% | $100.69M+9.2% | $92.17M-10.2% | ||
| $197.75M+62.9% | $121.39M+34.7% | $90.13M-13.0% | $103.61M+11.2% | $93.15M-10.3% | ||
| $2.08M+26.4% | $1.64M+20.5% | $1.36M-17.8% | $1.66M-15.6% | $1.97M-10.3% | ||
| $201.92M+61.3% | $125.2M+33.8% | $93.6M-11.7% | $105.97M+10.5% | $95.91M-10.3% | ||
| $7.24M+45.9% | $4.96M+21.9% | $4.07M+25.3% | $3.25M+88.1% | $1.73M+20.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | $0-100% | $4.23M-37.0% | $6.7M-26.9% | $9.17M-7.3% | ||
| $7.05M-21.6% | $9M-17.7% | $10.93M-25.7% | $14.72M-26.7% | $20.07M-46.5% | ||
| $1.05M+3.9% | $1.01M+3.6% | $973K+3.6% | $939K+3.9% | $904K+3.9% | ||
| $63.89M-12.8% | $73.27M+444% | $13.47M-14.5% | $15.76M-25.8% | $21.23M-47.6% | ||
| $733K+33.3% | $550K0.0% | $550K+0.2% | $549K+11.4% | $493K+5.1% | ||
| -$239.25M-3.8% | -$230.39M-14.7% | -$200.89M-5.9% | -$189.62M-2.6% | -$184.83M+3.8% | ||
| $138.03M+166% | $51.92M-35.2% | $80.12M-11.2% | $90.21M+20.8% | $74.68M+12.6% | ||
| $201.92M+61.3% | $125.2M+33.8% | $93.6M-11.7% | $105.97M+10.5% | $95.91M-10.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Candel Therapeutics, Inc.'s total assets?
- Candel Therapeutics, Inc. (CADL) holds $201.9M in total assets, up 110.5% year over year.
- How much debt does Candel Therapeutics, Inc. have?
- Candel Therapeutics, Inc. carries $2.8M in total debt against $138.0M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Candel Therapeutics, Inc. have?
- Candel Therapeutics, Inc. holds $194.8M in cash and equivalents.
- Can Candel Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 28.05 — current assets exceed current liabilities.
- Where does Candel Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Candel Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
